The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The CD47-SIRPα Immune Checkpoint
Open accessAbstract
The cytotoxic activity of myeloid cells is regulated by a balance of signals that are transmitted through inhibitory and activating receptors. The Cluster of Differentiation 47 (CD47) protein, expressed on both healthy and cancer cells, plays a pivotal role in this balance by delivering a “don’t eat me signal” upon binding to the Signal-regulatory protein alpha (SIRPα) receptor on myeloid cells. In this Perspective, we describe the current state of knowledge on the role of the CD47-SIRPα axis in physiological tissue homeostasis and as a promising therapeutic target in, amongst others, oncology, fibrotic diseases, atherosclerosis and stem cell therapies. In addition, we highlight where additional insight will be beneficial to allow optimal exploitation of this myeloid cell checkpoint as a target in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“As a final example of the role of CD47 as a physiological regulator of cell survival and cellular interactions, expression of CD47 has been shown to protect neuronal synapses from elimination during “synaptic pruning”, a developmental process in which microglia remove synaptic elements to form an organized brain circu…”
BackgroundMicroglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 4×
“C1q or C3 localization to neuronal synapses enhances microglia-dependent synaptic pruning by binding Mac-1 (Schafer et al. 2012; Stevens et al. 2007).”
BackgroundInfluentialThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247
Regulation and Function of the PD-L1 Checkpoint
Sun, C., Mezzadra, R., & Schumacher, T. N. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.014 · Cited by 2,193
Self-citationRole of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Self-citationCD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
MYC regulates the antitumor immune response through CD47 and PD-L1
Casey, S. C., Tong, L., Li, Y., Do, R., Walz, S., Fitzgerald, K. N., Gouw, A. M., Baylot, V., Gütgemann, I., Eilers, M., et al. (2016) · Science · doi:10.1126/science.aac9935 · Cited by 1,403
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1456-0 · Cited by 1,385
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature · doi:10.1038/nature23270 · Cited by 1,147 · cited 1×
“First, in a pooled genetic screen, CD47 deletion was shown to increase the sensitivity of melanoma cells to GVAX/ anti-PD-1 combination immunotherapy, and this effect was dependent on T cells (Manguso et al., 2017).”
BackgroundCD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Advani, R., Flinn, I., Popplewell, L., Forero, A., Bartlett, N. L., Ghosh, N., Kline, J., Roschewski, M., LaCasce, A., Collins, G. P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1807315 · Cited by 1,126
Chao, M. P., Alizadeh, A. A., Tang, C., Myklebust, J. H., Varghese, B., Gill, S., Jan, M., Cha, A. C., Chan, C. K., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,087
Integrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 878
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Liu, X., Pu, Y., Cron, K., Deng, L., Kline, J., Frazier, W. A., Xu, H., Peng, H., Fu, Y.-X., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 767
Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0016-3 · Cited by 758
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Kojima, Y., Volkmer, J.-P., McKenna, K., Civelek, M., Lusis, A. J., Miller, C. L., Direnzo, D., Nanda, V., Ye, J., Connolly, A. J., et al. (2016) · Nature · doi:10.1038/nature18935 · Cited by 683
A family of proteins that inhibit signalling through tyrosine kinase receptors
Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J., & Ullrich, A. (1997) · Nature · doi:10.1038/386181a0 · Cited by 662
Tseng, D., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Fathman, J. W., Fernhoff, N. B., Seita, J., Inlay, M. A., Weiskopf, K., Miyanishi, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305569110 · Cited by 657
Barkal, A. A., Weiskopf, K., Kao, K. S., Gordon, S. R., Rosental, B., Yiu, Y. Y., George, B. M., Markovic, M., Ring, N. G., Tsai, J. M., et al. (2018) · Nature Immunology · doi:10.1038/s41590-017-0004-z · Cited by 558
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509 · cited 1×
“As such, atherosclerotic lesions are at risk of rupture and obstruction, increasing the possibility of myocardial infarction and stroke (Kasikara et al., 2018; Schrijvers et al., 2005).”
BackgroundPolymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Takenaka, K., Prasolava, T. K., Wang, J. C. Y., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E., & Danska, J. S. (2007) · Nature Immunology · doi:10.1038/ni1527 · Cited by 509
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 495
Tsai, R. K., & Discher, D. E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708043 · Cited by 486
Alternative 3′ UTRs act as scaffolds to regulate membrane protein localization
Berkovits, B. D., & Mayr, C. (2015) · Nature · doi:10.1038/nature14321 · Cited by 474
CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development
Lehrman, E. K., Wilton, D. K., Litvina, E. Y., Welsh, C. A., Chang, S. T., Frouin, A., Walker, A. J., Heller, M. D., Umemori, H., Chen, C., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.017 · Cited by 468
Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis
Oldenborg, P.-A., Gresham, H. D., & Lindberg, F. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.855 · Cited by 452
Fujioka, Y., Matozaki, T., Noguchi, T., Iwamatsu, A., Yamao, T., Takahashi, N., Tsuda, M., Takada, T., & Kasuga, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6887 · Cited by 448
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
Strauss, L., Mahmoud, M. A. A., Weaver, J. D., Tijaro-Ovalle, N. M., Christofides, A., Wang, Q., Pal, R., Yuan, M., Asara, J., Patsoukis, N., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aay1863 · Cited by 437
Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520032112 · Cited by 420
Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia
Boas, F. E., Forman, L., & Beutler, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3077 · Cited by 405
Durable antitumor responses to CD47 blockade require adaptive immune stimulation
Sockolosky, J. T., Dougan, M., Ingram, J. R., Ho, C. C. M., Kauke, M. J., Almo, S. C., Ploegh, H. L., & Garcia, K. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604268113 · Cited by 366
Seiffert, M., Cant, C., Chen, Z., Rappold, I., Brugger, W., Kanz, L., Brown, E. J., Ullrich, A., & Bühring, H.-J. (1999) · Blood · doi:10.1182/blood.v94.11.3633 · Cited by 303
SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin
Chen, J., Zhong, M.-C., Guo, H., Davidson, D., Mishel, S., Lu, Y., Rhee, I., Pérez-Quintero, L.-A., Zhang, S., Cruz-Munoz, M.-E., et al. (2017) · Nature · doi:10.1038/nature22076 · Cited by 288
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Ring, N. G., Herndler-Brandstetter, D., Weiskopf, K., Shan, L., Volkmer, J.-P., George, B. M., Lietzenmayer, M., McKenna, K. M., Naik, T. J., McCarty, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710877114 · Cited by 283
Petrova, P. S., Viller, N. N., Wong, M., Pang, X., Lin, G. H. Y., Dodge, K., Chai, V., Chen, H., Lee, V., House, V., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1700 · Cited by 278
Zhao, X. W., van Beek, E. M., Schornagel, K., Van der Maaden, H., Van Houdt, M., Otten, M. A., Finetti, P., Van Egmond, M., Matozaki, T., Kraal, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106550108 · Cited by 276
The role of non-resolving inflammation in atherosclerosis
Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266
Signal-Regulatory Protein Is Selectively Expressed by Myeloid and Neuronal Cells
Adams, S., van der Laan, L. J. W., Vernon-Wilson, E., Renardel de Lavalette, C., Döpp, E. A., Dijkstra, C. D., Simmons, D. L., & van den Berg, T. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1853 · Cited by 258
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Chao, M. P., Takimoto, C. H., Feng, D. D., McKenna, K., Gip, P., Liu, J., Volkmer, J.-P., Weissman, I. L., & Majeti, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01380 · Cited by 252
Veillette, A., Thibaudeau, E., & Latour, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22719 · Cited by 245
Logtenberg, M. E. W., Jansen, J. H. M., Raaben, M., Toebes, M., Franke, K., Brandsma, A. M., Matlung, H. L., Fauster, A., Gomez-Eerland, R., Bakker, N. A. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0356-z · Cited by 240
Self-citationOldenborg, P.-A. (2013) · ISRN Hematology · doi:10.1155/2013/614619 · Cited by 235
Betancur, P. A., Abraham, B. J., Yiu, Y. Y., Willingham, S. B., Khameneh, F., Zarnegar, M., Kuo, A. H., McKenna, K., Kojima, Y., Leeper, N. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14802 · Cited by 235
In vivo expression of alternatively spliced forms of integrin-associated protein (cd47)
Reinhold, M. I., Lindberg, F. P., Plas, D., Reynolds, S., Peters, M. G., & Brown, E. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.11.3419 · Cited by 232
Mechanisms tagging senescent red blood cells for clearance in healthy humans
Lutz, H. U., & Bogdanova, A. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00387 · Cited by 218
Olsson, M., Bruhns, P., Frazier, W. A., Ravetch, J. V., & Oldenborg, P.-A. (2005) · Blood · doi:10.1182/blood-2004-08-2980 · Cited by 216
Unifying mechanism for different fibrotic diseases
Wernig, G., Chen, S.-Y., Cui, L., Van Neste, C., Tsai, J. M., Kambham, N., Vogel, H., Natkunam, Y., Gilliland, D. G., Nolan, G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621375114 · Cited by 206
Khandelwal, S., Van Rooijen, N., & Saxena, R. K. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01348.x · Cited by 187
Autio, K. A., Boni, V., Humphrey, R. W., & Naing, A. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1457 · Cited by 184
Localization of senescent cell antigen on band 3.
Kay, M. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.18.5753 · Cited by 175
Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
Chhabra, A., Ring, A. M., Weiskopf, K., Schnorr, P. J., Gordon, S., Le, A. C., Kwon, H.-S., Ring, N. G., Volkmer, J., Ho, P. Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0501 · Cited by 172
Brooke, G., Holbrook, J. D., Brown, M. H., & Barclay, A. N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2562 · Cited by 171
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Barcellini, W. (2015) · Transfusion Medicine and Hemotherapy · doi:10.1159/000439002 · Cited by 171
Programmed cell removal by calreticulin in tissue homeostasis and cancer
Feng, M., Marjon, K. D., Zhu, F., Weissman-Tsukamoto, R., Levett, A., Sullivan, K., Kao, K. S., Markovic, M., Bump, P. A., Jackson, H. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05211-7 · Cited by 160
Dheilly, E., Moine, V., Broyer, L., Salgado-Pires, S., Johnson, Z., Papaioannou, A., Cons, L., Calloud, S., Majocchi, S., Nelson, R. J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.006 · Cited by 151
Piccione, E. C., Juárez, S., Liu, J., Tseng, S., Ryan, C. E., Narayanan, C., Wang, L., Weiskopf, K., & Majeti, R. (2015) · mAbs · doi:10.1080/19420862.2015.1062192 · Cited by 148
Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47
Mouro-Chanteloup, I., Delaunay, J., Gane, P., Nicolas, V., Johansen, M. L., Brown, E. J., Peters, L. L., Kim, C. L. V., Cartron, J., & Colin, Y. (2002) · Blood · doi:10.1182/blood-2002-04-1285 · Cited by 145
Yamao, T., Noguchi, T., Takeuchi, O., Nishiyama, U., Morita, H., Hagiwara, T., Akahori, H., Kato, T., Inagaki, K., Okazawa, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203287200 · Cited by 140
Campbell, I., Freemont, P. S., Foulkes, W. D., & Trowsdale, J. (1992) · PubMed · Cited by 140
Localized CD47 blockade enhances immunotherapy for murine melanoma
Ingram, J. R., Blomberg, O. S., Sockolosky, J. T., Ali, L. R., Schmidt, F. I., Pishesha, N., Espinosa, C. A., Dougan, S. K., García, K. C., Ploegh, H. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710776114 · Cited by 139
Kong, X., Yan, H., Chen, L., Dong, L., Yang, W., Liu, Q., Yu, L., Huang, D., Liu, S., Liu, H., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062611 · Cited by 138
Fischer, N., Elson, G., Magistrelli, G., Dheilly, E., Fouque, N., Laurendon, A., Gueneau, F., Ravn, U., Depoisier, J.-F., Moine, V., et al. (2015) · Nature Communications · doi:10.1038/ncomms7113 · Cited by 120
Ishikawa-Sekigami, T., Kaneko, Y., Okazawa, H., Tomizawa, T., Okajo, J., Saito, Y., Okuzawa, C., Sugawara-Yokoo, M., Nishiyama, U., Ohnishi, H., et al. (2005) · Blood · doi:10.1182/blood-2005-05-1896 · Cited by 119
Buatois, V., Johnson, Z., Salgado-Pires, S., Papaioannou, A., Hatterer, E., Chauchet, X., Richard, F., Barba, L., Daubeuf, B., Cons, L., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1095 · Cited by 119
Ma, L., Zhu, M., Gai, J., Li, G., Chang, Q., Peng, Q., Cao, L., Chen, W., Zhang, S., & Wan, Y. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-0571-2 · Cited by 111
Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice
Oldenborg, P. (2002) · Blood · doi:10.1182/blood.v99.10.3500 · Cited by 108
SUZUKI, S., YOKOBORI, T., TANAKA, N., SAKAI, M., SANO, A., INOSE, T., SOHDA, M., NAKAJIMA, M., MIYAZAKI, T., KATO, H., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1831 · Cited by 100 · cited 1×
“Finally, CD47 expression levels in cancer cells have also been shown to be regulated by miR-133a (Suzuki et al., 2012), miR-192 (Yang et al.”
BackgroundTargeting CD47 in Sézary syndrome with SIRPαFc
Johnson, L. D. S., Banerjee, S., Kruglov, O., Viller, N. N., Horwitz, S. M., Lesokhin, A. M., Zain, J. M., Querfeld, C., Chen, R., Okada, C. Y., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018030577 · Cited by 100
Ho, C. C. M., Ring, N. G., Sockolosky, J. T., Ring, A. M., Weiskopf, K., Özkan, E., Mori, Y., Weissman, I. L., & García, K. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.648220 · Cited by 93
The CD47 “don't eat me signal” is highly expressed in human ovarian cancer
Brightwell, R. M., Grzankowski, K. S., Lele, S., Eng, K. H., Arshad, M., Chen, H., & Odunsi, K. O. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.08.325 · Cited by 86
George, B. M., Kao, K. S., Kwon, H.-S., Velasco, B. J., Poyser, J., Chen, A. C., Le, A., Chhabra, A., Burnett, C. E., Cajuste, D., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.018 · Cited by 75
Voets, E., Paradé, M., Hulsik, D. L., Spijkers, S., Janssen, W., Rens, J. A. P., Reinieren-Beeren, I., van den Tillaart, G., van Duijnhoven, S. M. J., Driessen-Engels, L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0772-0 · Cited by 72
Kuriyama, T., Takenaka, K., Kohno, K., Yamauchi, T., Daitoku, S., Yoshimoto, G., Kikushige, Y., Kishimoto, J., Abe, Y., Harada, N., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408864 · Cited by 70
Synapse maturation by activity-dependent ectodomain shedding of SIRPα
Toth, A. B., Terauchi, A., Zhang, L. Y., Johnson‐Venkatesh, E., Larsen, D. J., Sutton, M. A., & Umemori, H. (2013) · Nature Neuroscience · doi:10.1038/nn.3516 · Cited by 68
A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression
Myers, L. M., Tal, M. C., Torrez Dulgeroff, L. B., Carmody, A. B., Messer, R. J., Gulati, G., Yiu, Y. Y., Staron, M. M., Angel, C. L., Sinha, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08637-9 · Cited by 66
Dong, L., Kong, X., Yan, H., Yu, L., Chen, L., Yang, W., Liu, Q., Huang, D., Wu, M., & Wang, H. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.03.012 · Cited by 60
Cleavage of Signal Regulatory Protein α (SIRPα) Enhances Inflammatory Signaling
Londino, J. D., Gulick, D. L., Isenberg, J. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.682914 · Cited by 59
Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice
Li, Y., Zhang, M., Wang, X., Liu, W., Wang, H., & Yang, Y. (2020) · Nature Communications · doi:10.1038/s41467-019-14102-4 · Cited by 58
Zen, K., Guo, Y., Bian, Z., Lv, Z., Zhu, D., Ohnishi, H., Matozaki, T., & Liu, Y. (2013) · Nature Communications · doi:10.1038/ncomms3436 · Cited by 55
BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma
Liu, F., Jiang, C. C., Yan, X. G., Tseng, H., Wang, C. Y., Zhang, Y. Y., Yari, H., La, T., Farrelly, M. L., Guo, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17704 · Cited by 54
Sim, J., Sockolosky, J. T., Sangalang, E., Izquierdo, S. M., Pedersen, D., Harriman, W. D., Wibowo, A. S., Carter, J., Madan, A., Doyle, L. V., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1624123 · Cited by 52
Hatherley, D., Lea, S. M., Johnson, S., & Barclay, A. N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550558 · Cited by 51
SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells
Piccione, E. C., Juárez, S., Tseng, S., Liu, J., Stafford, M., Narayanan, C., Wang, L., Weiskopf, K., & Majeti, R. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2503 · Cited by 51
Yang, S. Y., Choi, S. A., Lee, J. Y., Park, A.-K., Wang, K., Phi, J. H., Koh, E. J., Park, W., Park, S., Hwang, D. W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6227 · Cited by 50
Subramanian, S., Tsai, R., Sen, S., Dahl, K. N., & Discher, D. E. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.01.012 · Cited by 39
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
He, Y. Z., Bouwstra, R., Wiersma, V. R., de Jong, M. R. W., Lourens, H. J., Fehrmann, R. S. N., de Bruyn, M., Ammatuna, E., Huls, G. A., van Meerten, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08013-z · Cited by 37
Liu, H., Li, L., Voss, C., Wang, F., Liu, J., & Li, S. S. ‐. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.047951 · Cited by 31
Ponce, L. P., Fenn, N. C., Moritz, N., Krupka, C., Kozik, J.-H., Lauber, K., Subklewe, M. S., & Hopfner, K. (2017) · Oncotarget · doi:10.18632/oncotarget.14500 · Cited by 30
Ichigotani, Y., Matsuda, S., Machida, K., Oshima, K., Iwamoto, T., Yamaki, K., Hayakawa, T., & Hamaguchi, M. (2000) · Journal of Human Genetics · doi:10.1007/s100380070013 · Cited by 25
Mushegian, A. R. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10073 · Cited by 20
Cited by
Immune checkpoint therapy—current perspectives and future directions
Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.006 · Cited by 1,206
Glioma targeted therapy: insight into future of molecular approaches
Yang, K., Wu, Z., Zhang, H., Zhang, N., Wu, W., Wang, Z., Dai, Z., Zhang, X., Zhang, L., Peng, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01513-z · Cited by 704
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Sun, Q., Hong, Z., Zhang, C., Wang, L., Han, Z., & Ma, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01522-4 · Cited by 598
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P., & Nelson, B. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00466-1 · Cited by 524
Metadata
- Authors
- Logtenberg, M. E. W., Scheeren, F. A., & Schumacher, T. N.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 52
- Issue
- 5
- Pages
- 742-752
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W3026660164
- Cited by
- 735
- References
- 96
- FWCI
- 20.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.